Archive for November, 2005
FDA Tentatively OKs Teva Insomnia Drug (AP via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsTeva Pharmaceutical Industries said on Wednesday it received tentative approval from the Food and Drug Administration to sell its 5 milligram and 10 milligram capsules of Zaleplon, a generic short-term treatment for insomnia.
Labopharm stock hits 20-month high after FDA lowers hurdle for new painkiller (Canadian Press via Yahoo! News)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsTORONTO (CP) - Labopharm Inc. stock hit a 20-month high Wednesday after it announced the U.S. Food and Drug Administration no longer requires it to do an additional clinical study of its once-daily version of the painkiller tramadol.
Older drugs may be risky in elderly - Miami Herald
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsOlder mental health drugs risky for elderlyReuters AlertNet, UK - 23 minutes ago… The Food and Drug Administration warned in April that newer "atypical" anti-psychotic medicines such as Johnson & Johnson's Risperdal and El…
Drug prompts safety alert (Miami Herald)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsA drug used to increase a woman’s chances of becoming pregnant may cause birth defects and miscarriages, according to a safety alert issued this week by Canadian health regulators.
Company asks FDA for approval of new drug - Roanoke Times
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsUPDATE 1-US FDA warns about Genzyme drug in MS trialReuters - 13 hours agoWASHINGTON, Nov 30 (Reuters) - The US Food and Drug Administration issued a health alert on Wednesday over the use of Genzyme Corp. …
VOA Organizes Health Journalism Workshop on Drug Resistance (Voice of America)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsPRESS RELEASE - November 29, 2005, Abuja, Nigeria — The Voice of America (VOA), which broadcasts in Hausa and English to listeners across Nigeria, has organized a workshop for Nigerian journalists to explore the issue of drug resistance and its impact on diseases such as malaria, tuberculosis, and HIV/AIDS.
Inspire Shares Up on Pending FDA Ruling (AP via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsShares of Inspire Pharmaceuticals Inc. surged Wednesday away from its 52-week low, the day before the Food and Drug Administration is due to rule on the company’s dry eye treatment.
Eye Drop Maker Agrees to FDA Order to Stop Manufacturing Products (Senior Journal)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsNov. 29, 2005 - The U.S. Food and Drug Administration (FDA) yesterday announced that MBI Distributing, Inc. (MBI) has agreed to cease manufacturing and distributing drugs until it corrects manufacturing deficiencies.
APP Gets FDA OK for Generic Unasyn (AP via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsAmerican Pharmaceutical Partners Inc. said Wednesday that the Food and Drug Administration granted approval for the drug maker to market a generic version of Pfizer Inc.’s antibiotic Unasyn.
Business News (Sharewatch)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsLEVERKUSEN, Germany (AFX) - Bayer AG’’s HealthCare unit said the US Food and Drug Administration (FDA) has approved its once-daily oral antibiotic drug Avelox for the treatment of complicated intra-abdominal infections, or stomach infections.
Looming FDA Trans Fat Labelling Deadline Causes No Reaction at Kettle Foods (Business Wire via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsSALEM, Ore.—-Nov. 30, 2005–Not all snack food companies are hustling to meet the January 2006 Food and Drug Administration deadline that forces the inclusion of trans fat content on nutrition labeling.
Drug dispensing errors closer to eradication - In-PharmaTechnologist.com
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsDrug dispensing errors closer to eradicationIn-PharmaTechnologist.com, France - 48 minutes ago… drug being dispensed, then compares the information with a drug ID library, and confirms quality compliance with Food and Drug Administration (F…
J&J Asks FDA to OK Schizophrenia Drug - MSN Money
Closed Published by Administrator November 30th, 2005 in Google FDA News, Regulatory AffairsJ&J Asks FDA to OK Schizophrenia DrugMSN Money - 1 hour agoThe new drug application with the Food and Drug Administration covers Paliperidone extended-release tablets, a once-daily oral medication. …
Apotex Receives Final Approval for Ofloxacin Otic 0.3% (Business Wire via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsWESTON, Fla.—-Nov. 30, 2005–Apotex Corp. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ofloxacin otic, 0.3%.
Predix Pharmaceuticals Obtains Special Protocol Assessment for PRX-00023 Pivotal Study in Anxiety (Business Wire via Yahoo! Finance)
Closed Published by Administrator November 30th, 2005 in Yahoo FDA News, Regulatory AffairsLEXINGTON, Mass. & RAMAT GAN, Israel—-Nov. 30, 2005–Predix Pharmaceuticals, a drug discovery and development company, announced today that under the Special Protocol Assessment process, it has reached final agreement with the United States Food and Drug Administration on the design and statistical analysis plan of its first pivotal study for PRX-00023, its 5-HT1A agonist and lead product
Search
About
You are currently browsing the Regulatory Affairs Syndicator weblog archives for November, 2005.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- March 2009
- December 2008
- November 2008
- October 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- May 2005
- January 2005
- December 1969
Categories
- AAPS PharmSciTech (1)
- AIDS Alert (1)
- Am J Cardiol (1)
- Am J Hosp Pharm (1)
- Am Pharm (1)
- Ann Intern Med (1)
- Ann Pharmacother (2)
- Ann Thorac Surg (1)
- Behav Brain Res (1)
- Biomed Instrum Technol (1)
- Can J Cardiol (1)
- Circulation (1)
- Clin Chem (1)
- Compend Contin Educ Dent (1)
- Congest Heart Fail (1)
- Conn Med (1)
- Consumers (2)
- Contracept Technol Update (1)
- Curr Concepts Hosp Pharm Manage (1)
- Curr Urol Rep (1)
- Dentomaxillofac Radiol (1)
- Drug Intell Clin Pharm (1)
- Expert Rev Med Devices (1)
- FDA Consum (1)
- Fed Regist (8)
- Food Drug Law J (2)
- Food Safety (188)
- Google FDA News (15596)
- Health Devices (2)
- Healthc Hazard Mater Manage (2)
- Heart Rhythm (1)
- Home Healthc Nurse (1)
- Hosp Mater Manage Q (1)
- Hosp Technol Ser (1)
- Hospitals (1)
- Int J Health Serv (1)
- Int J Trauma Nurs (1)
- Int Psychogeriatr (1)
- J Allergy Clin Immunol (1)
- J Am Board Fam Pract (1)
- J Am Coll Dent (1)
- J Am Coll Surg (1)
- J Am Diet Assoc (3)
- J Am Med Inform Assoc (1)
- J Am Pharm Assoc (1)
- J Can Dent Assoc (2)
- J Card Fail (1)
- J Clin Eng (1)
- J Clin Pharmacol (1)
- J Drugs Dermatol (1)
- J Emerg Med (1)
- J Endod (1)
- J Environ Pathol Toxicol (1)
- J Expo Anal Environ Epidemiol (1)
- J Food Prot (1)
- J Healthc Mater Manage (1)
- J Immunol (1)
- J Neural Eng (1)
- J Neurosurg Spine (1)
- J Proteome Res (1)
- J Thorac Cardiovasc Surg (1)
- J Vasc Surg (1)
- JAMA (3)
- Lancet (3)
- Magn Reson Med (1)
- Med Device Technol (6)
- Med Law (1)
- Med World News (1)
- Medical Devices (38)
- MMWR Morb Mortal Wkly Rep (1)
- Mod Healthc (3)
- NIH (354)
- Nippon Hoshasen Gijutsu Gakkai Zasshi (1)
- NY Times (Print) (2)
- OR Manager (1)
- Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1)
- Pa Med (1)
- Pacing Clin Electrophysiol (1)
- Patient Safety (143)
- PDA J Pharm Sci Technol (1)
- Pediatrics (1)
- Public Health Rep (1)
- PubMed Medical Devices (42)
- PubMed Recall (86)
- Purch Adm (2)
- Recalls (202)
- Regulatory Affairs (32687)
- Rev Elev Med Vet Pays Trop (1)
- Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (1)
- Stud Health Technol Inform (1)
- Surg Endosc (1)
- Time (1)
- Transfus Med Rev (1)
- Transfusion (1)
- Uncategorized (4476)
- US News World Rep (1)
- Vaccine (1)
- Value Health (1)
- Women Health (1)
- Yahoo FDA News (8060)
Content Cloud
advisers american announces approval arthritis backs boston canada chronicle debate europe faster financial francisco gilead helps home inquirer jose journal marketwatch mercury panel pfizer philadelphia pill press prevent preventive release report review risks star street study test times used wall washington york